Set and Setting: How Huxley and Osmond Built the Clinical Framework

“The phrase 'set and setting' is attributed to Timothy Leary, but the concept was built by Osmond and Huxley, letter by letter, between 1953 and 1963. Leary named it. They invented it.”

The concept of set and setting is now so fundamental to psychedelic research that it appears in the safety guidelines of every clinical trial, in the training materials of every facilitator program, and in the published recommendations of every professional organization working in the field. Set, the mindset, expectations, and psychological state of the person taking the substance. Setting, the physical environment, social context, and relational conditions in which the experience occurs. The two variables together, clinicians now understand, predict a substantial proportion of the variance in psychedelic experience quality and therapeutic outcome.

The phrase is attributed to Timothy Leary, who used it in lectures during the Harvard psilocybin project in the early 1960s. But the concept was developed by Humphry Osmond and Aldous Huxley through a decade of correspondence, beginning with Osmond's May 1953 mescaline session with Huxley in Los Angeles and elaborated across hundreds of letters.

Osmond's clinical contribution was the observation that the same dose of the same substance produced dramatically different experiences in different people and in different contexts. He had seen this at Weyburn: patients who received LSD in the same protocol reported experiences ranging from peaceful insight to terror. The variable was not the drug. The variable was the person and the situation.

Huxley's contribution was the philosophical framework: the drug did not add content to consciousness but removed filters. What was revealed when the filters were removed depended enormously on what was already there, the person's beliefs, anxieties, hopes, and emotional state, and on what the environment provided, whether it was frightening or safe, chaotic or structured, cold or warm. The drug was an amplifier, not a specific producer. What it amplified was everything.

The correspondence worked out the practical implications of this framework over years of reflection. Huxley described his own sessions, the first mescaline session with Osmond, subsequent LSD sessions, his wife's use of psychedelics, with systematic attention to what conditions had contributed to positive outcomes: familiar surroundings, trusted companions, beautiful art, carefully chosen music, freedom from interruption, absence of time pressure. He was building, empirically, a list of set and setting variables based on direct experience.

Osmond was doing the same thing clinically. The Weyburn LSD protocol that produced 40-50 percent sobriety rates in alcoholic patients was not simply 'give LSD.' It was preparation (discussing the experience in advance, establishing trust), dosing (in a carefully prepared room with meaningful objects and music), and integration (follow-up sessions to process what had happened). These three phases, preparation, session, integration, are now the standard clinical model for psychedelic-assisted therapy, formalized in Johnson et al.'s 2008 safety guidelines and mandated by the protocols of every current clinical trial.

A 2024 correlational survey study in Expert Review of Clinical Pharmacology (Borkel et al.) found, consistent with what Huxley and Osmond had argued seventy years earlier, that set and setting variables predict psychopathology, wellbeing, and meaningfulness of psychedelic experiences across independent samples. A 2024 review of integration session frameworks (Thal & Lommen, Clinical Psychology & Psychotherapy) synthesized 75 clinical trials and found that the therapeutic alliance and the quality of preparation and integration sessions were significant predictors of outcome across conditions.

The letters in Moksha are not simply historical documents. They are the first systematic working-out of what is now the foundational clinical infrastructure of the psychedelic renaissance. When a clinical trial at Johns Hopkins or Imperial College specifies preparation requirements, therapist training, session environment, and integration follow-up, it is implementing the framework that Huxley and Osmond developed letter by letter between 1953 and 1963.

Leary named it. He condensed a decade of careful clinical and philosophical development into a slogan, 'set and setting', that was both accurate and easily misunderstood. The slogan suggested that you could control the experience by controlling the variables, which was true in a general sense and false in a specific sense: set and setting shape the experience, they do not determine it. The difference between shaping and determining is the difference between a clinical framework and a guarantee, and Leary's promotional style often presented it as the latter.

Huxley and Osmond's letters are the guarantee-free version: two careful people working out, from direct experience and clinical observation, what conditions most reliably support positive outcomes while acknowledging that the experience remains fundamentally unpredictable. This is the epistemic posture that current clinical research is recovering, the posture that Leary's showmanship temporarily obscured.

Sources

• Huxley & Osmond, in Moksha (1977)
• Hartogsohn, Constructing drug effects: a history of set and setting, Drug Sci Policy Law (2017)
• Borkel et al., Set and setting predict psychopathology, wellbeing and meaningfulness, Expert Rev Clin Pharmacol (2024)
• Thal & Lommen, Therapeutic frameworks in integration sessions, Clin Psychol Psychother (2024) [Source not found; under review]
• Johnson et al., Human hallucinogen research guidelines for safety, J Psychopharmacol (2008)